Surgery Partners Inc (SGRY)
24.53
-0.47
(-1.88%)
USD |
NASDAQ |
May 03, 16:00
24.57
+0.04
(+0.16%)
After-Hours: 20:00
Surgery Partners Enterprise Value: 7.060B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 7.060B |
| May 02, 2024 | 7.119B |
| May 01, 2024 | 7.072B |
| April 30, 2024 | 7.113B |
| April 29, 2024 | 7.089B |
| April 26, 2024 | 7.062B |
| April 25, 2024 | 7.099B |
| April 24, 2024 | 7.182B |
| April 23, 2024 | 7.167B |
| April 22, 2024 | 6.998B |
| April 19, 2024 | 6.971B |
| April 18, 2024 | 6.919B |
| April 17, 2024 | 7.052B |
| April 16, 2024 | 7.082B |
| April 15, 2024 | 7.204B |
| April 12, 2024 | 7.287B |
| April 11, 2024 | 7.238B |
| April 10, 2024 | 7.279B |
| April 09, 2024 | 7.447B |
| April 08, 2024 | 7.417B |
| April 05, 2024 | 7.428B |
| April 04, 2024 | 7.379B |
| April 03, 2024 | 7.434B |
| April 02, 2024 | 7.501B |
| April 01, 2024 | 7.610B |
| Date | Value |
|---|---|
| March 28, 2024 | 7.731B |
| March 27, 2024 | 7.745B |
| March 26, 2024 | 7.650B |
| March 25, 2024 | 7.572B |
| March 22, 2024 | 7.475B |
| March 21, 2024 | 7.533B |
| March 20, 2024 | 7.519B |
| March 19, 2024 | 7.461B |
| March 18, 2024 | 7.438B |
| March 15, 2024 | 7.558B |
| March 14, 2024 | 7.594B |
| March 13, 2024 | 7.585B |
| March 12, 2024 | 7.717B |
| March 11, 2024 | 7.700B |
| March 08, 2024 | 7.689B |
| March 07, 2024 | 7.753B |
| March 06, 2024 | 7.855B |
| March 05, 2024 | 7.815B |
| March 04, 2024 | 7.815B |
| March 01, 2024 | 7.903B |
| February 29, 2024 | 7.883B |
| February 28, 2024 | 7.902B |
| February 27, 2024 | 7.985B |
| February 26, 2024 | 7.777B |
| February 23, 2024 | 8.137B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.842B
Minimum
Aug 15 2019
9.454B
Maximum
Apr 20 2022
6.560B
Average
7.004B
Median
Aug 25 2022
Enterprise Value Benchmarks
| DaVita Inc | 22.27B |
| Healthcare Services Group Inc | 731.95M |
| Encompass Health Corp | 11.61B |
| The Oncology Institute Inc | 83.49M |
| American Oncology Network Inc | 288.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.00M |
| Revenue (Quarterly) | 735.40M |
| Total Expenses (Quarterly) | 595.90M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 26.33% |
| Profit Margin (Quarterly) | -0.14% |
| Earnings Yield | -0.41% |
| Operating Earnings Yield | 13.25% |
| Normalized Earnings Yield | 2.429 |